腋窝淋巴结阳性乳腺癌患者接受新辅助化疗后行前哨淋巴结活检可行性的Meta分析 Feasibility of Sentinel Lymph Node Biopsy After Neoadjuvant Chemotherapy in Patient with Breast Cancer and Positive Axillary Nodes at Initial Diagnosis:A Meta Analysis
Rebollo-Aguirre AC,Gallego-Peinado M,Snchez-Snchez R,et al.Sentinel lymph node biopsy after neoadjuvant chemotherapy in patients with operable breast cancer and positive axillary nodes at initial diagnosis[J].Rev Esp Med Nucl Imagen Mol,2013,32(4):240-245.
[2]
Fontein DB,Water W,Mieog JS,et al.Timing of the sentinel lymph node biopsy in breast cancer patients receiving neoadjuvant therapy-Recommendations for clinical guidance[J].Eurg J Surg Oncol,2013,39(5):417-424.
[3]
Takahashi M,Jinno H,Hayashida T,et al.Correlation between clinical nodal status and sentinel lymph node biopsy false negative rate after neoadjuvant Chemotherapy[J].World J Surg,2012,36(12):2 847-2 852.
[4]
Canavese G,Dozin B,Vecchio C,et al.Accuracy of sentinel lymph node biopsy after neoadjuvant chemotherapy in patients with locally advanced breast cancer and clinically positive axillary nodes[J].Eur J Surg Oncol,2011,37(8):688-694.
Goldhirsch A,Ingle JN,Gelber RD,et al.Thresholds for therapies:highlights of the ST gallen international expert consensus on the primary therapy of early breast cancer 2009[J].Ann Oncol,2009,20(8):1 319-1 329.
[7]
Kuehn T,Bauerfeind I,Fhm T,et al.Sentinel-lymphnode biopsy in patients with breast cancer before and after neoadjuvant chemotherapy(SENTINA):aprospective,multicentre cohort study[J].Lancet Oncol,2013,14(7):609-618.
[8]
Yagata H,Yamauchi H,Tsugawa K,et al.Sentinel node biopsy after neoadjuvant chemotherapy in cytologically proven node-positive breast cancer[J].Clin Breast Cancer,2013,13(6):471-477.
[9]
Park S,Park JM,Cho JH,et al.Sentinel lymph node biopsy after neoadjuvant chemotherapy in patients with cytologically proven node-positive breast cancer at diagnosis[J].Ann Surg Oncol,2013,20(9):2 858-2 865.
[10]
Lee S,Kim EY,Kang SH,et al.Sentinel node identification rate,but not accuracy,is significantly decreased after pre-operative chemotherapy in axillary node-positive breast cancer patients[J].Breast Cancer Res Treat,2007,102(3):283-288.
[11]
Kinoshita T.Sentinel lymph node biopsy is feasible for breast cancer patients neoadjuvant chemotherapy[J].Breast Cancer,2007,14(1):10-15.
[12]
Newman EA,Sabel MS,Nees AV,et al.Sentinel lymph node biopsy performed after neoadjuvant chemotherapy is accurate in patients with documented nodepositive breast cancer at presentation[J].Ann Surg Oncol,2007,14(10):2 946-2 952.
[13]
Lyman GH,Giuliano AE,Somerfield MR,et al.American society of clinical oncology guideline recommendations for sentinel lymph node biopsy in early-stage breast cancer[J].Clin Oncol,2005,23(30):7 703-7 720.
[14]
Tan VK,Goh BK,Fook-Chong S,et al.The feasibility and accuracy of sentinel lymph node biopsy in clinicallynode-negative patients after neoadjuvant chemotherapy for breast cancer e a systematic review and meta-analysis[J].J Surg Oncol,2011,104(1):97-103.
[15]
Xing Y,Foy M,Cox DD,et al.Meta-analysis of sentinel lymph node biopsy after preoperative chemotherapy in patient with breast cancer[J].Br J Surg,2006,93(5):539-546.
